CrowdStrike

Keybanc analyst Eric Heath maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Overweight and raises the price target from $245 to $318.

CrowdStrike (NASDAQ:CRWD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/16/2024 1.44% Truist Securities $230 → $290 Maintains Buy 01/12/2024 -16.05% Cantor Fitzgerald → $240 Reiterates Overweight → Overweight 01/10/2024 11.94% Citigroup $275 → $320 Maintains Buy 01/09/2024 6.34% Morgan Stanley $203 → $304 Upgrades Equal-Weight → Overweight 01/05/2024 4.94% Oppenheimer $240 → $300 Maintains Outperform 12/21/2023 10.19% Rosenblatt $245 → $315 Maintains Buy 12/21/2023 13.68% Needham $250 → $325 Maintains Buy 12/15/2023 -5.55% BMO Capital $238 → $270 Maintains Outperform 12/15/2023 -3.81% Mizuho $225 → $275 Maintains Buy 12/11/2023 -5.9% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -22.35% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -19.55% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -21.3% Mizuho $205 → $225 Maintains Buy 11/29/2023 -16.05% Stifel $225 → $240 Maintains Buy 11/29/2023 -17.8% JMP Securities → $235 Reiterates Market Outperform

Truist Securities analyst Patrick Scholes maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $230 to $290.

CrowdStrike (NASDAQ:CRWD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/12/2024 -15.42% Cantor Fitzgerald → $240 Reiterates Overweight → Overweight 01/10/2024 12.77% Citigroup $275 → $320 Maintains Buy 01/09/2024 7.13% Morgan Stanley $203 → $304 Upgrades Equal-Weight → Overweight 01/05/2024 5.73% Oppenheimer $240 → $300 Maintains Outperform 12/21/2023 11.01% Rosenblatt $245 → $315 Maintains Buy 12/21/2023 14.54% Needham $250 → $325 Maintains Buy 12/15/2023 -4.85% BMO Capital $238 → $270 Maintains Outperform 12/15/2023 -3.09% Mizuho $225 → $275 Maintains Buy 12/11/2023 -5.2% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -21.76% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -18.94% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -20.71% Mizuho $205 → $225 Maintains Buy 11/29/2023 -15.42% Stifel $225 → $240 Maintains Buy 11/29/2023 -17.18% JMP Securities → $235 Reiterates Market Outperform → Market Outperform 11/29/2023 -28.46% Morgan Stanley $187 →

CrowdStrike (NASDAQ:CRWD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/10/2024 14.1% Citigroup $275 → $320 Maintains Buy 01/09/2024 8.39% Morgan Stanley $203 → $304 Upgrades Equal-Weight → Overweight 01/05/2024 6.97% Oppenheimer $240 → $300 Maintains Outperform 12/21/2023 12.32% Rosenblatt $245 → $315 Maintains Buy 12/21/2023 15.88% Needham $250 → $325 Maintains Buy 12/15/2023 -3.73% BMO Capital $238 → $270 Maintains Outperform 12/15/2023 -1.95% Mizuho $225 → $275 Maintains Buy 12/11/2023 -4.09% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -20.84% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -17.99% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -19.77% Mizuho $205 → $225 Maintains Buy 11/29/2023 -14.43% Stifel $225 → $240 Maintains Buy 11/29/2023 -16.21% JMP Securities → $235 Reiterates Market Outperform → Market Outperform 11/29/2023 -27.62% Morgan Stanley $187 → $203 Maintains Equal-Weight 11/29/2023 -14.43% Canaccord Genuity $221 → $240

Citigroup analyst Fatima Boolani maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $275 to $320.

CrowdStrike (CRWD) is set to see improved demand due to rising cyberattacks, new products, and generative artificial intelligence tailwinds, Morgan Stanley said in a note Tuesday. The analysts said they were upgrading the stock based on “improving demand, broader platform traction, and multiple product cycles still ramping up,” including Charlotte AI. Ransomware attacks are on the rise, driving stronger demand for CrowdStrike’s incident response and endpoint security services, and boosting the company’s professional services revenue. This is one of the key indicators for stronger subscription demand and shows why CrowdStrike is set to outperform in 2024, the analysts said. The company has also expanded from core endpoint protection to a broader platform as well as remains strongly positioned to leverage and monetize GenAI, given its leadership in securing endpoints, the analysts said, adding that they expect the recently launched Charlotte AI to add $100 million in annual recurring revenue by

By Angela Palumbo CrowdStrike Holdings stock took off after a Morgan Stanley analyst raised his target for the price by 50%, citing mounting cyberattacks and new technology meant to fight them. Morgan Stanley analyst Hamza Fodderwala upgraded shares of CrowdStrike to Overweight from Equal Weight and increased his price target to $304 from $203 on Tuesday. That implies a 16% increase from the stock’s closing price of $261.28 on Monday. “We see an improving demand outlook for CRWD as accelerating cyberattacks, multiple new products and GenAI tailwinds drive estimates upside,” Fodderwala said in a research note. CrowdStrike helps clients to prevent and deal with breaches. Demand for its products and services is high as cyberattacks continued to proliferate last year. Clorox, Alphabet’s Google, MGM Resorts International and Caesars Entertainment all faced attacks in 2023. “Ransomware attacks are accelerating, up >70% last year. This is driving stronger demand for CRWD’s incident

CrowdStrike (NASDAQ:CRWD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/09/2024 14.07% Morgan Stanley $203 → $304 Upgrades Equal-Weight → Overweight 01/05/2024 12.57% Oppenheimer $240 → $300 Maintains Outperform 12/21/2023 18.2% Rosenblatt $245 → $315 Maintains Buy 12/21/2023 21.95% Needham $250 → $325 Maintains Buy 12/15/2023 1.31% BMO Capital $238 → $270 Maintains Outperform 12/15/2023 3.19% Mizuho $225 → $275 Maintains Buy 12/11/2023 0.94% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -16.7% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -13.7% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -15.57% Mizuho $205 → $225 Maintains Buy 11/29/2023 -9.94% Stifel $225 → $240 Maintains Buy 11/29/2023 -11.82% JMP Securities → $235 Reiterates Market Outperform → Market Outperform 11/29/2023 -23.83% Morgan Stanley $187 → $203 Maintains Equal-Weight 11/29/2023 -9.94% Canaccord Genuity $221 → $240 Maintains Buy 11/29/2023 -8.07% Piper Sandler $210 →

CrowdStrike (NASDAQ:CRWD) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/05/2024 20.6% Oppenheimer $240 → $300 Maintains Outperform 12/21/2023 26.63% Rosenblatt $245 → $315 Maintains Buy 12/21/2023 30.65% Needham $250 → $325 Maintains Buy 12/15/2023 8.54% BMO Capital $238 → $270 Maintains Outperform 12/15/2023 10.55% Mizuho $225 → $275 Maintains Buy 12/11/2023 8.14% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -10.75% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -7.54% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -9.55% Mizuho $205 → $225 Maintains Buy 11/29/2023 -3.52% Stifel $225 → $240 Maintains Buy 11/29/2023 -5.53% JMP Securities → $235 Reiterates Market Outperform → Market Outperform 11/29/2023 -18.39% Morgan Stanley $187 → $203 Maintains Equal-Weight 11/29/2023 -3.52% Canaccord Genuity $221 → $240 Maintains Buy 11/29/2023 -1.51% Piper Sandler $210 → $245 Maintains Overweight 11/29/2023 -3.52% Cantor Fitzgerald $180 → $240 Maintains

Needham analyst Alex Henderson maintains CrowdStrike Holdings (NASDAQ:CRWD) with a Buy and raises the price target from $250 to $325.

CrowdStrike (NASDAQ:CRWD) Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 12/15/2023 8.35% Mizuho $225 → $275 Maintains Buy 12/11/2023 5.98% JP Morgan $230 → $269 Maintains Overweight 11/30/2023 -12.53% Goldman Sachs $195 → $222 Maintains Buy 11/29/2023 -9.38% Truist Securities → $230 Reiterates Buy → Buy 11/29/2023 -11.35% Mizuho $205 → $225 Maintains Buy 11/29/2023 -5.44% Stifel $225 → $240 Maintains Buy 11/29/2023 -7.41% JMP Securities → $235 Reiterates Market Outperform → Market Outperform 11/29/2023 -20.02% Morgan Stanley $187 → $203 Maintains Equal-Weight 11/29/2023 -5.44% Canaccord Genuity $221 → $240 Maintains Buy 11/29/2023 -3.47% Piper Sandler $210 → $245 Maintains Overweight 11/29/2023 -5.44% Cantor Fitzgerald $180 → $240 Maintains Overweight 11/29/2023 -6.23% BMO Capital $227 → $238 Maintains Outperform 11/29/2023 -21.2% Wedbush → $200 Reiterates Outperform → Outperform 11/29/2023 -5.44% Oppenheimer $215 → $240 Maintains Outperform 11/29/2023 -9.38% JP Morgan $210 → $230